Immune Function in Patients with Rheumatoid Arthritis Treated with Etanercept

By Moreland L.W.   Bucy R.P.   Weinblatt M.E.   Mohler K.M.   Spencer-Green G.T.   Chatham W.W.  

Clinical Immunology, Vol. 103, Iss. 1, 2002-04 ,pp. : 13-21

Academic Press

Access to resources Recommend Favorite

Persistence of Immune Responses to Altered and Native Myelin Antigens in Patients with Multiple Sclerosis Treated with Altered Peptide Ligand

By Kim H.J.   Antel J.P.   Duquette P.   Alleva D.G.   Conlon P.J.   Bar-Or A.  

Clinical Immunology, Vol. 104, Iss. 2, 2002-08 ,pp. : 105-114

Academic Press

Access to resources Recommend Favorite

Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy

By Savès M.   Morlat P.   Chêne G.   Peuchant E.   Pellegrin I.   Bonnet F.   Bernard N.   Lacoste D.   Salamon R.   Beylot J.  

Clinical Immunology, Vol. 99, Iss. 3, 2001-06 ,pp. : 347-352

Academic Press

Access to resources Recommend Favorite

Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double‐blind placebo‐controlled study

By  

Immunity, Inflammation And Disease, Vol. 3, Iss. 2, 2015-06 ,pp. : 45-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stimulation of the Developing Immune System Can Prevent Autoimmunity

By Singh B.  

Journal of Autoimmunity, Vol. 14, Iss. 1, 2000-02 ,pp. : 15-22

Academic Press

Access to resources Recommend Favorite